Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
PG Coulie, BJ Van den Eynde… - Nature Reviews …, 2014 - nature.com
In this Timeline, we describe the characteristics of tumour antigens that are recognized by
spontaneous T cell responses in cancer patients and the paths that led to their identification …
spontaneous T cell responses in cancer patients and the paths that led to their identification …
Cancer/testis antigens, gametogenesis and cancer
AJG Simpson, OL Caballero, A Jungbluth… - Nature Reviews …, 2005 - nature.com
Abstract Cancer/testis (CT) antigens, of which more than 40 have now been identified, are
encoded by genes that are normally expressed only in the human germ line, but are also …
encoded by genes that are normally expressed only in the human germ line, but are also …
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
MJ Scanlan, AO Gure, AA Jungbluth… - Immunological …, 2002 - Wiley Online Library
Cancer/testis (CT) antigens are a category of tumor antigens with normal expression
restricted to male germ cells in the testis but not in adult somatic tissues. In some cases, CT …
restricted to male germ cells in the testis but not in adult somatic tissues. In some cases, CT …
Cancer/testis (CT) antigens: potential targets for immunotherapy
OL Caballero, YT Chen - Cancer science, 2009 - Wiley Online Library
Cancer/testis (CT) antigens are protein antigens with normal expression restricted to adult
testicular germ cells, and yet are aberrantly activated and expressed in a proportion of …
testicular germ cells, and yet are aberrantly activated and expressed in a proportion of …
[HTML][HTML] The biology of cancer testis antigens: putative function, regulation and therapeutic potential
E Fratta, S Coral, A Covre, G Parisi, F Colizzi… - Molecular …, 2011 - Elsevier
Cancer testis antigens (CTA) are a large family of tumor-associated antigens expressed in
human tumors of different histological origin, but not in normal tissues except for testis and …
human tumors of different histological origin, but not in normal tissues except for testis and …
The cancer/testis genes: review, standardization, and commentary
MJ Scanlan, AJ G Simpson, LJ Old - Cancer immunity, 2004 - AACR
Cancer/testis (CT) antigens are immunogenic in cancer patients, exhibit highly tissue-
restricted expression, and are considered promising target molecules for cancer vaccines …
restricted expression, and are considered promising target molecules for cancer vaccines …
Biology of cancer-testis antigens and their therapeutic implications in cancer
DS Nin, LW Deng - Cells, 2023 - mdpi.com
Tumour-specific antigens have been an area of interest in cancer therapy since their
discovery in the middle of the 20th century. In the era of immune-based cancer therapeutics …
discovery in the middle of the 20th century. In the era of immune-based cancer therapeutics …
Methylation matters
JF Costello, C Plass - Journal of medical genetics, 2001 - jmg.bmj.com
DNA methylation is not just for basic scientists any more. There is a growing awareness in
the medical field that having the correct pattern of genomic methylation is essential for …
the medical field that having the correct pattern of genomic methylation is essential for …
Dead-box proteins: a family affair—active and passive players in RNP-remodeling
P Linder - Nucleic acids research, 2006 - academic.oup.com
ABSTRACT DEAD-box proteins are characterized by nine conserved motifs. According to
these criteria, several hundreds of these proteins can be identified in databases. Many …
these criteria, several hundreds of these proteins can be identified in databases. Many …
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino, C Castelli, G Parmiani - Cancer Immunology, Immunotherapy, 2005 - Springer
The technological advances occurred in the last few years have led to a great increase in
the number of tumor associated antigens (TAA) that are currently available for clinical …
the number of tumor associated antigens (TAA) that are currently available for clinical …